<![CDATA[ Your latest Press Releases ]]> 10<![CDATA[ Rosetta Genomics Initiates Closing of Private Placement ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=10198 <![CDATA[ Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=10445 <![CDATA[ Study Showing Potential for microRNAs as Biomarkers for Heart Failure Prognosis Published in European Journal of Heart Failure ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=10918 <![CDATA[ Rosetta Genomics Announces New York State Approval for miRview mets² ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=11174 <![CDATA[ Rosetta Genomics Sells Ownership in Rosetta Green ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=11343 <![CDATA[ Rosetta Announces $1.75 Million Debt Financing and Potential $1.25 Million Licensing Transaction ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=12040 <![CDATA[ Rosetta Genomics to Present Multiple Poster Presentations at the 101st Annual Meeting of the United States and Canadian Academy of Pathology ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=13224 <![CDATA[ Study Published in International Journal of Oncology Shows Potential for microRNAs to Determine Risk of Recurrence in Colorectal Cancer ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=13250 <![CDATA[ Rosetta Genomics to Raise $1.38 Million in Registered Direct Offering ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=13782 <![CDATA[ Rosetta Genomics Receives Key European Patent in Oncology ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=13962 <![CDATA[ Rosetta Genomics Receives Key U.S. Patent Allowance ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=14025 <![CDATA[ Rosetta Genomics Announces One-for-Fifteen Reverse Stock Split ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=14607 <![CDATA[ Rosetta Genomics Announces Launch of miRview Kidney ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=14649 <![CDATA[ Rosetta Genomics Achieves Major Commercial Milestone by Obtaining Medicare Coverage of miRview mets2 Assay ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=14713 <![CDATA[ Rosetta Genomics to Raise $2.2 Million in Registered Direct Offering ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=14745 <![CDATA[ Rosetta Genomics to Raise $6.6 Million in Registered Direct Offering ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=14946 <![CDATA[ Study Validating miRview mets2 Published in The Oncologist ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=14953 <![CDATA[ Data on Two of Rosetta Genomics' Launched Diagnostic Assays to Be Presented at ASCO 2012 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=15051 <![CDATA[ Rosetta Genomics Announces Compliance With Continued Listing Requirements of The NASDAQ Capital Market ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=15178 <![CDATA[ Rosetta Genomics Appoints Roy N. Davis to Board of Directors ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=15179 <![CDATA[ Rosetta Genomics Secures Medicare Reimbursement Pricing for miRview® mets2 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=15473 <![CDATA[ Rosetta Genomics Pays Off Secured Loan and Reclaims Unencumbered Rights to All Assets ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=15561 <![CDATA[ Rosetta Genomics Announces New York State Approval for miRview® lung ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=15593 <![CDATA[ Study Validating Rosetta Genomics' miRview lung Assay Published in Journal of Molecular Diagnostics ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=15730 <![CDATA[ Rosetta Genomics and Precision Therapeutics Enter into Co-Marketing Agreement for miRview® mets2 Assay ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=16151 <![CDATA[ Rosetta Genomics Announces Pricing of Public Offering of 5.5 Million Ordinary Shares ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=16376 <![CDATA[ Rosetta Genomics Announces Closing of Public Offering of 5.5 Million Ordinary Shares ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=16505 <![CDATA[ Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=16591 <![CDATA[ Rosetta Genomics Expands Management Team, Laboratory Capacities and Commercial Operations ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=16769 <![CDATA[ Rosetta Genomics Announces Exercise and Closing of Underwriter's Over-Allotment Option ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=16961 <![CDATA[ Rosetta Genomics To Host Business Update Conference Call on October 2, 2012 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=17250 <![CDATA[ Rosetta Genomics to Present at the 2012 Aegis Healthcare Conference ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=17369 <![CDATA[ Rosetta Genomics and Precision Therapeutics Announce U.S. Commercial Launch of miRview® mets2 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=17597 <![CDATA[ Rosetta Genomics Expands Management Team with Chief Medical Officer and Chief Scientific Officer ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=17883 <![CDATA[ New York State Grants Final Approval for miRview® lung; Expands Access for Rosetta Genomics' microRNA Diagnostic for Identification of Four Major Subtypes of Lung Cancer ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=18522 <![CDATA[ Rosetta Genomics to Appoint Dr. Yitzhak Peterburg to its Board of Directors ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=18613 <![CDATA[ Rosetta Genomics Added to Ocean Tomo 300 Patent Index ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=18884 <![CDATA[ Rosetta Genomics to Present at Sidoti & Company 2013 Micro-Cap Conference ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=20067 <![CDATA[ Rosetta Genomics Reports Study Comparing microRNA Profiles of Cancer of Unknown Primary and Metastases of Known Primary Tumors Published in Clinical Experimental Metastasis ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=20178 <![CDATA[ Rosetta Genomics to be Featured on The Balancing Act® Airing on Lifetime Television Network ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=20748 <![CDATA[ Study Validating Ability of microRNAs to Predict Progression of Bladder Cancer Published in British Journal of Urology International ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=20977 <![CDATA[ Rosetta Genomics Receives Two Key U.S. Patent Allowances ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21139 <![CDATA[ Rosetta Genomics to Present at the 25th Annual Roth Conference ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21649 <![CDATA[ Rosetta Genomics Receives 25th U.S. Patent Allowance ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21740 <![CDATA[ Rosetta Genomics To Host Business Update Conference Call on April 10, 2013 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=21890 <![CDATA[ Rosetta Genomics Announces Acceptance for Publication of Kidney Cancer microRNA Diagnostic Manuscript by Molecular Oncology ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22012 <![CDATA[ Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013 ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22060 <![CDATA[ Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22325 <![CDATA[ Rosetta Genomics microRNA-based Diagnostic Assays to be showcased in an Industry Expert Theater Presentation at ASCO's 2013 Annual Meeting ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22659 <![CDATA[ Rosetta Genomics Receives Full Settlement Payment from Sanra Laboratories ]]> http://www.macreportmedia.com/ViewSubmission.aspx?submissionRequest=22755